Karyopharm Therapeutics | Salgsomkostninger Og Administration

Selling And Administration Expenses Lave om Dato
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Avrobio USD 6.26M 1.68M 2023-09
GlaxoSmithKline GBP 2.18B 6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Takeda JPY 252.95B 4.84B 2023-09
TG Therapeutics USD 31.15M 1.62M 2023-12
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Xencor USD 15.48M 2.98M 2023-12



Karyopharm Therapeutics Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.